The instrument is compact but contains several interpretative and definitional mechanisms that determine its legal effect.

Declaration mechanism

• Clause 4 effects a legal classification: the Schedule 1 substances are "declared to be drugs of dependence for the purposes of section 3 of the Poisons Act 1971" (clause 4). The order itself does not contain regulatory obligations or penalties; it changes the legal status of named substances under the referenced Act.

Scope-expansion rules

• Clause 3(3) systematically expands what is meant by a "substance specified" in the order. A named entry in Schedule 1 embraces that same chemical when prepared from natural or artificial sources (3(3)(a)), and, for plants (subject to an exception), the plant or part when prepared for therapeutic use (3(3)(b)). It also reaches salts, active principals, derivatives (including esters and ethers) (3(3)(c)), alkaloids and their salts (3(3)(d)), stereo-isomers and their salts (3(3)(e)), recombinant forms (3(3)(f)), and any preparation or admixture containing any proportion of the substance (3(3)(g)). Those provisions make the declaration chemically and product-wise broad, subject to the subsequent exclusions.

Cross-references and shorthand

• Clause 3(2) establishes the shorthand "S" followed by a number as a reference to that numbered Schedule to the Poisons List. Several Schedule 1 items carry parenthetical S references; the order thereby links those entries to the wider Poisons List architecture.

Exclusions and concentration thresholds

• Clause 3(3)(h)-(j) carves out three exclusion categories. The order excludes preparations/products listed in Appendix A to the Uniform Standard (3(3)(h)), substances in Appendix G at or below specified concentrations (3(3)(i)), and substances that are listed in Schedules 1-6 to the Poisons List where the concentration does not exceed 10 mg per litre or 10 mg per kilogram, unless also in Schedule 7 or 8 (3(3)(j)). Those exclusions anchor the reach of the declaration to scheduling and concentration thresholds in external standards.

Quantitative calculation rules

• Clause 3(4)(a) directs that concentration, strength or quantity be calculated as the equivalent amount of the substance listed where the substance is present as a salt, active principal or derivative. Clause 3(4)(b) defines "1%" as 1 g per 100 mL for liquids and 1 g per 100 g for solids/semi-solids. Clause 3(4)(c) gives a specific rule for codeine, which must be calculated as anhydrous codeine.

External instrument linkage

• Clause 3(5) expressly imports the Commonwealth Uniform Standard published under the Therapeutic Goods Act 1989, as amended. The order thereby ties its exclusions and some interpretive content to a Commonwealth instrument that may be amended independently.

Administrative note

• The order records its Gazette notification date, 5 August 2009, and lists the Department of Health and Human Services as the administering agency.

The order alters the legal classification of a roster of substances by declaring them to be drugs of dependence for the purposes of section 3 of the Poisons Act 1971 (clause 4). The direct and immediate set of actors affected, as derivable from the text, are anyone who handles, produces, supplies, imports, prescribes, dispenses, stores, or otherwise deals with the named substances or products containing them in the relevant jurisdiction.

Scope of affected substances

• The Schedule includes 47 named substances (Schedule 1, items 1-47). Clause 3(3) expands the reach of each named entry to salts, derivatives, stereoisomers, alkaloids, recombinant forms and mixtures containing any proportion of the named substance. That expansion brings within the order’s operation not only the parent chemical but also a wide set of chemical forms and product presentations. For example, an ester or salt of a listed benzodiazepine will, by clause 3(3)(c) and (e), fall within the declaration if it is the equivalent amount of the listed substance.

Businesses and product types likely affected

• Manufacturers and formulators that produce chemical derivatives, salts, stereo-isomers, recombinant versions or admixtures of listed substances are included by the broad formulations in clause 3(3)(c)-(g). Pharmacies, wholesalers, hospitals and clinicians that possess, prescribe or dispense formulations that contain any proportion of a listed substance are also within the ambit because clause 3(3)(g) reaches preparations and admixtures containing any proportion. Because clause 3(3)(b) extends to plants or parts prepared for therapeutic use (subject to Schedule 8 or 9 exceptions), herbal or botanical product suppliers that present a plant-derived therapeutic that contains a listed substance will be affected unless an exclusion applies.

Interplay with external scheduling and thresholds

• The order’s exclusions refer to Appendix A and Appendix G of the Uniform Standard and to Schedules 1-6 and 7-8 of the Poisons List (clause 3(3)(h)-(j)). Those cross-references mean that suppliers and manufacturers must check not only the instrument’s Schedule 1 but also the Uniform Standard and the Poisons List schedules to determine whether their particular product falls inside or outside the declaration.

Regulatory actors and administrators

• The instrument is administered by the Department of Health and Human Services, which is recorded at the end of the order. That department will be the point of contact for compliance and administration matters referenced by the text.

Note on boundaries

• The order itself does not specify licences, permit regimes, offences, penalties or operational controls. Those operational consequences, by the terms of the instrument, will flow from the status conferred under section 3 of the Poisons Act 1971 (clause 4). The order therefore affects those subject to the Poisons Act 1971’s regulatory apparatus by changing which substances attract that Act’s provisions.

The order does not itself create a substantive regime of obligations or rights beyond declaring a list of substances to be drugs of dependence for the purposes of section 3 of the Poisons Act 1971 (clause 4). Nevertheless, the order creates duties and rights by operation of that cross-reference. The order also imposes certain interpretative duties on those who must apply it.

Duty to treat listed substances as drugs of dependence for Poisons Act purposes

• Clause 4 is the operative declaration: for the purposes of s 3 of the Poisons Act 1971, the Schedule 1 substances are "drugs of dependence". That constitutes a legal duty to treat those substances as falling within whatever regulatory consequences section 3 and the Poisons Act impose. The order does not itself specify what those consequences are. A person required to comply with the Poisons Act must therefore apply the Act to substances declared under clause 4.

Duty to interpret substance references broadly

• Clause 3 places an interpretative duty on regulated actors, compliance officers and enforcement bodies to read a named substance expansively. Where a product contains a salt, derivative, alkaloid, stereoisomer, recombinant form or admixture, the product is to be treated as the listed substance unless an exclusion applies (clause 3(3)(c)-(g)). That requires businesses and regulators to assess chemical form and to calculate equivalent amounts (clause 3(4)(a)).

Duty to check cross-referenced documents for exclusions and concentrations

• The exclusions in clause 3(3)(h)-(j) require duty-holders to consult the Uniform Standard’s Appendix A and G and the Poisons List Schedules 1-8 to determine whether a product is excluded from the declaration. Clause 3(5) expressly defines the "Uniform Standard" as the Commonwealth Standard published under the Therapeutic Goods Act 1989, as amended, therefore requiring consultees to monitor amendments to that external instrument.

Duty to perform concentration calculations correctly

• Clause 3(4) sets precise calculation rules. Where a substance is present as a salt or derivative, concentration, strength or quantity is to be calculated as the equivalent amount of the listed substance (3(4)(a)). The meaning of "1%" is defined by reference to grams per 100 mL for liquids and grams per 100 g for solids/semi-solids (3(4)(b)). Codeine must be calculated as anhydrous codeine (3(4)(c)). Those provisions create a duty on manufacturers, laboratories and compliance personnel to perform conversions in accordance with the clause before concluding whether an exclusion applies.

Rights implied by the order

• The order does not confer express statutory rights. Its practical effect is to change the legal status of the named substances. Any rights that follow will be those the Poisons Act 1971 grants or preserves for persons dealing with substances that are declared to be drugs of dependence. The order’s text does not enumerate those rights.

Administrative rights and obligations

• The order is administered by the Department of Health and Human Services. That department’s administrative role is recorded on the instrument but is not further specified in this text.

Interpretative duty under Acts Interpretation Act

• Clause 3(1) brings the Acts Interpretation Act 1931 into play, applying it to the order as if the order were by-laws. That creates a legal duty on users and courts to apply the interpretative rules of the Acts Interpretation Act when construing this order.

The order itself does not establish new offences, penalties or enforcement powers. It performs a classification function: it declares the listed substances to be drugs of dependence for the purposes of section 3 of the Poisons Act 1971 (clause 4). Any penalties and enforcement mechanisms that apply to those substances therefore arise by operation of the Poisons Act 1971 and any subordinate instruments made under that Act, not by this order.

What the instrument states

• Clause 4 limits the instrument’s text to the declaratory act. There is no penal or enforcement language, no schedules of fines, no application procedures, and no authorisation of inspections in the order itself.

Consequences flowing to enforcement

• Because the order changes statutory classification, the practical enforcement consequences will be determined by the Poisons Act 1971. Administrators, inspectors, prosecutors and regulated parties will need to apply the Poisons Act and any subordinate rules to determine applicable offences, compliance requirements, and sanctions. The order makes no changes to that enforcement architecture on its face.

Administrative responsibility

• The instrument identifies the Department of Health and Human Services as the administering agency. That identifies the likely point of regulatory oversight for matters arising from the declaration, including enforcement questions generated by treating the listed substances as drugs of dependence.

Enforcement ambiguity and implementation risk

• The absence of enforcement text in the order means that regulated parties cannot identify enforcement modalities from this instrument alone. Parties must consult the Poisons Act 1971 and the Poisons List and other subordinate instruments referenced in clause 3 to discover the relevant offences, permit or licence requirements, record-keeping duties and sanction regimes. Clause 3(1) requires interpretation under the Acts Interpretation Act 1931, which assists textual construction but does not itself create enforcement detail.

Interaction with external schedules and standards

• Clause 3(3)(h)-(j) links the order’s substantive reach to the Uniform Standard and to concentrations and schedules in the Poisons List. Enforcement authorities will therefore need to apply that external material in enforcement decisions. Changes to those external instruments could alter enforcement coverage, and the order explicitly imports the Uniform Standard "as amended from time to time" (clause 3(5)), which creates an implementation linkage that enforcement bodies must track.

The order is designed to operate within a broader regulatory framework and contains explicit cross-references to other instruments. The text makes those interactions primary features rather than implicit consequences.

Interaction with the Poisons Act 1971

• Clause 4 declares that the Schedule 1 substances are drugs of dependence "for the purposes of section 3 of the Poisons Act 1971". The order therefore functions as a classification instrument that triggers application of the Poisons Act 1971’s provisions. The order does not reproduce or amend the Poisons Act; instead it changes which substances fall under the Act’s relevant definitions by declaration. Determination of obligations, authorisations, offences, penalties and enforcement therefore depends on the content of the Poisons Act 1971, which is outside this instrument’s text.

Interaction with the Poisons List

• Clause 3(2) directs that a reference to a substance followed by "(S)" and a number is a reference to that substance when included in the correspondingly numbered Schedule to the Poisons List. Several Schedule 1 items carry an "(S4)" or similar parenthetical. This cross-reference integrates the order with the Poisons List scheduling architecture. Clause 3(3)(j) explicitly uses the Poisons List Schedules 1-8 to define an exclusion based on concentration thresholds.

Interaction with the Commonwealth Uniform Standard

• Clause 3(5) defines "Uniform Standard" as the Commonwealth Standard for the Uniform Scheduling of Drugs and Poisons published under the Therapeutic Goods Act 1989, as amended. Clause 3(3)(h)-(i) excludes certain items that are included in Appendix A or Appendix G of that Uniform Standard. The order therefore depends on an external Commonwealth instrument to delimit its scope. The Uniform Standard is imported "as amended from time to time", creating an ongoing, dynamic interaction: future amendments to the Commonwealth instrument may affect which products are excluded or included under this order.

Interpretation regime

• Clause 3(1) applies the Acts Interpretation Act 1931 to the order as if it were by-laws. That imports the statutory interpretative rules from the Acts Interpretation Act into the construction of this instrument. The order thereby avoids bespoke interpretative provisions and relies on established statutory interpretation methodology.

Concentration calculation and chemical equivalence

• Clause 3(4)(a) makes concentration and strength calculations depend on chemical equivalence when substances appear as salts or derivatives. Clause 3(4)(b) standardises percentage calculations for liquids and solids. Clause 3(4)(c) imposes a special calculation rule for codeine. Those technical rules ensure interaction between the order and labelling/analytical practices when applying the Poisons List thresholds or the Uniform Standard exclusions.

No express interaction with other Acts beyond the above

• The instrument makes explicit cross-references only to the Poisons Act 1971, the Poisons List schedules, the Uniform Standard under the Therapeutic Goods Act 1989, and the Acts Interpretation Act 1931. It does not itself reference other health, criminal, customs, therapeutic goods or controlled substances Acts. Where practical interactions with other Acts exist in regulatory reality, they are not spelled out in this instrument and must be located in those other instruments.

The text of the instrument contains limited metadata about its origin and status.

Commencement

• Clause 2 states that the order takes effect on the day on which the Poisons Amendment Act 2009 commences. The order therefore is tied to the commencement of that Act. The instrument itself does not list any subsequent amendments.

Gazette notification and administration

• The instrument records that it was notified in the Gazette on 5 August 2009 and that it is administered in the Department of Health and Human Services. Those notifications are included at the end of the text.

Imported and amending instruments

• Clause 3(5) imports the Commonwealth Uniform Standard "as amended from time to time", which means that the Uniform Standard’s later amendments alter the referential landscape of this order’s exclusions. The order itself contains no amending schedule or history beyond the commencement linkage and Gazette notification.

Absence of internal amendment provisions

• The order includes no internal mechanism for amendment, no staged implementation schedule and no sunset provision. Any amendment to the list of declared substances would require a further statutory instrument or legislative change under the enabling power in the Poisons Act architecture. The order does not itself describe that process.

No amendment record in the instrument

• The instrument, as provided, does not include a historical list of amendments or versions. Users seeking an amendment history must consult the published legislative database or the instrument register, which are outside the text of the order.

The text contains no references to litigation, court decisions, declaratory proceedings or any judicial interpretation. There is no recorded case law, no judicially interpreted clauses, and no mention of legal disputes in the instrument.

What the instrument provides

• The order is purely declaratory and administrative in draft. It includes no commentary about legal challenges or prior judicial consideration. It does not incorporate or cite any legal precedent, nor does it anticipate, define or modify judicial review mechanisms beyond the general law.

Implication for researchers

• Because the instrument contains no litigation history, researchers or practitioners wanting to know whether any of its provisions have been litigated, interpreted, or affected by case law must consult external legal databases, tribunal decisions and court records in respect of the Poisons Act 1971 and the Uniform Standard. The instrument itself provides no internal guide to such litigation.

Practical consequence

• For compliance and risk assessment purposes, absence of litigation history in the instrument means that stakeholders must assume that legal questions about the instrument’s scope, especially the interpretative breadth in clause 3(3) and concentration calculations in clause 3(4), may be unresolved and could be the subject of future disputes. The order does not identify settled points of law.

The instrument’s brevity hides several items that create practical compliance traps. Those pitfalls arise from the text’s interpretative breadth and its cross-references to external instruments.

Broad coverage by form and derivative

• Clause 3(3)(c)-(g) expands a named substance to cover salts, active principals, derivatives (including esters and ethers), alkaloids and their salts, stereo-isomers and recombinant forms, and preparations containing any proportion. That phrasing can sweep in products that are chemically related or present in trace amounts. A substance presented as a derivative or a stereoisomer will nevertheless be captured unless an exclusion elsewhere applies. Compliance officers must therefore test not just the common name but chemical identity and analytical equivalence.

Preparations and admixtures at any proportion

• Clause 3(3)(g) makes a preparation or admixture containing any proportion of the listed substance fall within the declaration. Even minute contaminant levels may bring a product into scope, unless the product falls within one of the express exclusions. That raises the need for precise quantitative analysis and careful consideration of manufacturing cross-contamination, labelling and testing protocols.

Plant material treated as a substance when therapeutically prepared

• Clause 3(3)(b) includes a plant or any part of it when packed or prepared for therapeutic use, unless the plant is included in Schedule 8 or 9 to the Poisons List or is a prohibited plant. Suppliers of herbal remedies and botanical therapeutics must check both the Poisons List schedules and the Schedule 1 list. The instrument does not define "packed or prepared for therapeutic use", so regulated parties must apply general interpretative principles under the Acts Interpretation Act 1931 (clause 3(1)) and sector practice.

Complex exclusions tied to external instruments and thresholds

• The exclusions in clause 3(3)(h)-(j) require contemporaneous reference to Appendix A and Appendix G of the Commonwealth Uniform Standard and to Schedules 1-8 of the Poisons List, including concentration thresholds (for example, the 10 mg per litre or 10 mg per kilogram limit in 3(3)(j)). Practically, that means a product’s status may turn on an external schedule entry or a small concentration measurement. The Uniform Standard is "as amended from time to time" (3(5)), so a change at Commonwealth level can alter whether a product is excluded.

Calculation and labelling pitfalls

• Clause 3(4)(a) mandates that concentrations be calculated as the equivalent amount of the listed substance when present as a salt or derivative. Clause 3(4)(b) defines "1%" precisely for liquids and solids. Laboratories and manufacturers must ensure conversion factors, molecular weights and salt/anhydrous calculations (notably codeine per clause 3(4)(c)) are applied consistently. Failure to use the specific conversion rules may lead to incorrect classification.

Parenthetical S references change meaning

• Several Schedule 1 items include a parenthetical S4 or similar. Clause 3(2) instructs that such parenthetical references are references to the corresponding Schedule to the Poisons List. That means a reader must consult the Poisons List schedule to understand the full regulatory context for those items. Ignoring the (S) shorthand may produce an incomplete view.

No enforcement or operational detail in the instrument

• The order declares substances but contains no operational rules, licensing conditions or penalties. Parties cannot rely on the order alone to determine obligations, permits, record-keeping requirements, or reporting duties; they must consult the Poisons Act 1971 and related subordinate instruments.

Administrative point of contact

• The Department of Health and Human Services is named as the administering agency. Failure to engage with that department for clarification could impede compliance, but the order supplies no procedural or contact details beyond naming the department.

Temporal uncertainty linked to commencement

• Clause 2 ties commencement to the day the Poisons Amendment Act 2009 commences. That can create a temporal dependency: users must confirm the Act’s commencement date to know when the declaration took effect.

This order is a classification device. Compliance therefore requires treating the Schedule 1 substances as drugs of dependence for the purposes of section 3 of the Poisons Act 1971 and taking steps to verify whether particular products fall inside or outside the declaration under the order’s interpretative rules.

Step 1 , Identify substances in your supply chain

• Cross-check product formulations, active ingredients and raw materials against Schedule 1 (items 1-47). Remember that the Schedule names are not exhaustive in form: clause 3(3) brings salts, derivatives, esters, ethers, alkaloids and their salts, stereo-isomers, recombinant forms and any preparation containing any proportion of a listed substance within the declaration. Do not rely solely on trade names or common names.

Step 2 , Perform chemical-form and concentration analysis

• For each product that potentially contains a listed substance, establish whether the product contains the parent substance, a salt, an ester, a stereoisomer, an alkaloid, a recombinant form or any admixture (clause 3(3)(c)-(g)). Apply the calculation rule in clause 3(4)(a) to convert salts or derivatives into the equivalent amount of the listed substance. Use the percentage definitions in clause 3(4)(b) for label and formulation checks. For codeine, calculate as anhydrous codeine per clause 3(4)(c).

Step 3 , Check exclusions against the Uniform Standard and the Poisons List

• Determine whether the product is explicitly excluded by clause 3(3)(h)-(j). That requires consulting Appendix A and Appendix G of the Commonwealth Uniform Standard and checking the relevant Schedules (1-8) of the Poisons List. For Appendix G exclusions, compare the product’s concentration with the concentration specified in Appendix G for that substance. For low-concentration exclusions under clause 3(3)(j), check whether the substance is listed in Schedules 1-6 and whether the concentration is at or below 10 mg per litre or 10 mg per kilogram, and also verify whether the substance is included in Schedule 7 or 8, in which case the exclusion does not apply.

Step 4 , Map legal consequences under the Poisons Act 1971

• Because clause 4 declares these substances for the purposes of section 3 of the Poisons Act 1971, identify what obligations the Poisons Act 1971 imposes on persons dealing with drugs of dependence. The order does not list or change those obligations; you must consult the Poisons Act and any subordinate instruments to determine licensing, storage, prescribing, dispensing, recordkeeping and disposal obligations, and potential offences and penalties.

Step 5 , Operationalise compliance systems

• Where products fall within the declaration:
  • Update product classification and labelling records.
  • Ensure analytical testing protocols support the calculation rules of clause 3(4).
  • Revise procurement, storage and handling procedures to meet whatever obligations the Poisons Act 1971 requires for drugs of dependence.
  • Train staff on the broader definitions in clause 3(3), including documentary evidence requirements for salts, derivatives, stereoisomers and recombinant forms.

Step 6 , Engage with the Department of Health and Human Services

• The instrument records that it is administered by the Department of Health and Human Services. For administrative guidance, clarification on interpretation, or to confirm whether a product is excluded by an Appendix or Poisons List entry, contact the administering department. The order provides the administering agency but not procedural contacts or forms.

Step 7 , Monitor external instruments and commencement timing

• The Uniform Standard is imported "as amended from time to time" (clause 3(5)). Monitor updates to the Commonwealth Standard and the Poisons List Schedules because they can affect exclusions and coverage under this order. Also confirm the effective date by verifying the commencement of the Poisons Amendment Act 2009 (clause 2) and any subsequent amendments or instruments affecting the Poisons List.

Step 8 , Document the compliance position

• Keep a documented legal and technical assessment for each product, showing:
  • The chemical identity and whether it is a listed substance or a covered derivative (clause 3(3)).
  • The concentration calculations and conversion factors used in line with clause 3(4).
  • The result of consultation with Appendix A, Appendix G and the Poisons List Schedules for exclusion tests (clause 3(3)(h)-(j)).
  • Any correspondence with the administering department and steps taken to align with the Poisons Act 1971 obligations triggered by clause 4.

Caveat

• The order is declaratory; it does not set out the downstream obligations, licences, offences or penalties that arise from classification under section 3 of the Poisons Act 1971. Compliance requires reading this order together with the Poisons Act 1971, the Poisons List and the Uniform Standard. Follow the interpretative rules in the Acts Interpretation Act 1931 when construing ambiguous points (clause 3(1)).